Stanford University
Showing 431-440 of 1,652 Results
-
Ugur Parlatan
Basic Life Research Scientist, Rad/Canary Center at Stanford for Cancer Early Detection
BioDr. Ugur Parlatan, PhD in physics, specializes in optics with a focus on its medical applications, particularly in characterizing extracellular vesicles through molecular fingerprinting. His research aims to advance optical techniques for improved disease diagnostics.
-
Vanessa Parli
Managing Director of Programs and External Engagement, Institute for Human-Centered Artificial Intelligence (HAI)
BioAs Managing Director, Programs and External Engagement at the Stanford Institute for Human-Centered Artificial Intelligence (HAI), I lead initiatives that foster interdisciplinary collaboration and connect academic research with real-world impact. My work includes managing HAI’s industry research partnerships, executive education, policy engagement and the AI Index, creating opportunities for leaders from diverse backgrounds to engage with cutting-edge AI research, its applications, and its potential for positive social impact.
Before joining Stanford, I worked in management consulting, applying statistics, machine learning, and data science to advise government agencies, biotech firms, and nonprofit organizations. My work centered on making complex methods accessible to decision makers, ensuring technical rigor translated into actionable strategies.
I hold an MS in Engineering Management and Computational Mathematics from Johns Hopkins University and a BA in Industrial Engineering from Arizona State University. I am passionate about turning bold ideas into impact, and am recognized for my collaborative, process-driven approach to problem-solving. -
Jane Parnes
Professor of Medicine, Emerita
Current Research and Scholarly InterestsThe lab is studying the mechanisms controlling B cell responsiveness and the balance between tolerance and autoimmunity. B cells deficient in CD72 are hyperresponsive to stimulation through the B cell receptor. We are examining the alterations in B cell signaling in these B cells and the mechanisms by which CD72 deficiency partially abrogates anergic tolerance. We hope to learn how deficiency in CD72 leads to spontaneous autoimmunity and increased susceptibility to induced autoimmune disease.
